Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Mol Genet Metab. 2020 May 11;130(3):183–196. doi: 10.1016/j.ymgme.2020.05.003

Figure 5:

Figure 5:

Propionyl-CoA (P-CoA) sources and their relative contribution in different disease states. Three different formulations were used to simulate different disease states: 1) ‘Baseline metabolic state’ 2) ‘Catabolic state’ or 3) “MAX catabolic state’ (Table S1). One P-CoA precursor at a time was replaced with its 13C-labeled analog within each media formulation and 13C-P-CoA (blue) was measured and % contribution was calculated. Endogenous 12C-P-CoA produced from the other unlabeled precursors is shown in gray bars. N= 4 biological replicates, N=1 technical replicates.